Create Stock SIPAutomate your investments in this
Performance
Total traded value
0.01 CrFundamentals
| Market Cap | ₹45Cr |
| ROE | -4.84% |
| P/E Ratio(TTM) | -7.98 |
| EPS(TTM) | -4.52 |
| P/B Ratio | 0.39 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.86 |
| Book Value | 93.51 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
Financials
*All values are in Rs. Cr
About Medi Caps
Medi-Caps Limited is an Indian company that has strategically transitioned from pharmaceutical manufacturing to focus on the real estate sector, concentrating on city-centric property development. Its primary vision is to undertake the development of premium residential and commercial properties by strategically acquiring land to capitalize on market opportunities. The company's governance philosophy is built on a strong commitment to values and ethical business conduct to enhance investor confidence and shareholder returns. A key business activity includes generating revenue from its real estate division, with its first project being the 'Medicaps Business Park'. In line with this new direction, the company has revisited its core values to align with the changing business scenario and its updated organizational growth plans. The company successfully generated revenue of ₹716.54 Lakhs from this project in the 2023-24 financial year, marking a significant operational milestone.;
| Parent Organisation | Medi Caps Limited |
| Managing Director | Alok K Garg |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Other Domestic Institutions